The relation of plasma homocysteine to radiographic knee osteoarthritis
- PMID: 19073367
- PMCID: PMC2758241
- DOI: 10.1016/j.joca.2008.11.015
The relation of plasma homocysteine to radiographic knee osteoarthritis
Abstract
Objective: Homocysteine has been implicated in multiple diseases that involve changes in structural tissue. In vitro studies have found that it alters the structure of collagen cross-linking thus affecting stability and mineralization such as that occurring in bone tissue. In the present study we considered the possible relationship between plasma homocysteine levels and the development and progression of knee osteoarthritis (OA).
Methods: The study question was posed in 691 men and 966 women from the original and offspring cohorts of the Framingham Osteoarthritis Study. We divided individuals into three groups according to plasma homocysteine levels and compared their risk for the development of new and progression of existing OA. We adjusted for potential confounders including age, body mass index, weight change, and physical activity.
Results: In the crude analysis, men in the middle homocysteine tertile were found to be at a greater risk than men in the lowest tertile for incident OA [odds ratios of 1.9 (1.1-3.5)]. This result persisted after adjusting for covariates [odds: 2.0, (1.1-3.8)]. No significant correlation was seen in women for the development of OA. In the evaluation of progression no significant trends were seen for both men and women.
Conclusions: Although cellular and molecular studies of homocysteine-related pathophysiology suggest a possible correlation between plasma homocysteine levels and OA, the present clinical study did not conclusively demonstrate such an association. However, further research is needed to explore the role of homocysteine in specific aspects of OA etiopathogenesis.
Conflict of interest statement
References
-
- Fowler B. Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. Seminars in Vascular Medicine. 2005;5(2):77–86. [Review] [74 refs] - PubMed
-
- Nair AP, Nemirovsky D, Kim M, Geer EB, Farkouh ME, Winston J, et al. Elevated homocysteine levels in patients with end-stage renal disease. Mount Sinai Journal of Medicine. 2005;72(6):365–73. - PubMed
-
- Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clinical Chemistry. 1993;39(9):1764–79. [Review] [129 refs] - PubMed
-
- van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der KM, de Jonge R, Lindemans J, et al. Homocysteine levels and the risk of osteoporotic fracture. New England Journal of Medicine. 2004;350(20):2033–41. see comment. - PubMed
-
- McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, et al. Homocysteine as a predictive factor for hip fracture in older persons. New England Journal of Medicine. 2004;350(20):2042–9. see comment. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
